ABP Stock Analysis: Buy, Sell, or Hold?
ABP - Abpro Holdings, Inc Common Stock
$0.52
-0.28 (-34.76%)
▼
5d:
-37.03%
30d:
-84.04%
90d:
-91.5%
WAIT
LOW Confidence
Analysis Updated: Feb 20, 2026 12:00 AM ET
Get Alerted When ABP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABP is down 37.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ABP is down 37.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABP is currently trading at $0.52, which is considered fair based on recent price action.
Technical Outlook: Technically, ABP is in a strong downtrend. The price is currently testing key support at $0.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 34.8% recently.
Market Sentiment: ABP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.00 (+283.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABP is in a strong downtrend. The price is currently testing key support at $0.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 34.8% recently.
Market Sentiment: ABP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.00 (+283.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
51/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-34.8%)
- BULLISH: Trading 283.1% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -37.0% 5-day decline - wait for stabilization
Support & Resistance Levels
Support Level
$0.52
Resistance Level
$2.89
Current Trend
Strong Downtrend
Technical data as of
Feb 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.08
Wall Street Target
$2.00
(+283.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 15, 2026 3:14 AM ET
Data refreshes hourly during market hours. Next update: 4:14 AM
Data refreshes hourly during market hours. Next update: 4:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 60 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |